Cita APA

Parladé, E., Tarrés Freixas, F., Favaro, M. T., Lascorz, J., Marquez-Matínez, M., Mendoza, R., . . . Villaverde, A. (2025). Subcutaneous administration of an endocrine-mimetic, slow-release protein material reduces the severity of SARS-CoV-2 infection.

Citación estilo Chicago

Parladé, Eloi, et al. Subcutaneous Administration of an Endocrine-mimetic, Slow-release Protein Material Reduces the Severity of SARS-CoV-2 Infection. 2025.

Cita MLA

Parladé, Eloi, et al. Subcutaneous Administration of an Endocrine-mimetic, Slow-release Protein Material Reduces the Severity of SARS-CoV-2 Infection. 2025.